Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362493312> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4362493312 abstract "<div>Abstract<p>The receptor tyrosine kinase KIT is an established oncogenic driver of tumor growth in certain tumor types, including gastrointestinal stromal tumors, in which constitutively active mutant forms of KIT represent an actionable target for small-molecule tyrosine kinase inhibitors. There is also considerable potential for KIT to influence tumor growth indirectly based on its expression and function in cell types of the innate immune system, most notably mast cells. We have evaluated syngeneic mouse tumor models for antitumor effects of an inhibitory KIT mAb, dosed either alone or in combination with immune checkpoint inhibitors. Anti-KIT mAb treatment enhanced the antitumor activity of anti–CTLA-4 and anti–PD-1 mAbs, and promoted immune responses by selectively reducing the immunosuppressive monocytic myeloid-derived suppressor cell population and by restoring CD8<sup>+</sup> and CD4<sup>+</sup> T-cell populations to levels observed in naïve mice. These data provide a rationale for clinical investigation of the human KIT-specific mAb KTN0158 in novel immuno-oncology combinations with immune checkpoint inhibitors and other immunotherapeutic agents across a range of tumor types. <i>Mol Cancer Ther; 16(4); 671–80. ©2017 AACR</i>.</p></div>" @default.
- W4362493312 created "2023-04-05" @default.
- W4362493312 creator A5001816025 @default.
- W4362493312 creator A5006528431 @default.
- W4362493312 creator A5006809501 @default.
- W4362493312 creator A5026623309 @default.
- W4362493312 creator A5031638977 @default.
- W4362493312 creator A5032279076 @default.
- W4362493312 creator A5061558144 @default.
- W4362493312 creator A5066301151 @default.
- W4362493312 creator A5071544928 @default.
- W4362493312 creator A5082159021 @default.
- W4362493312 date "2023-04-03" @default.
- W4362493312 modified "2023-09-26" @default.
- W4362493312 title "Data from Anti-KIT Monoclonal Antibody Treatment Enhances the Antitumor Activity of Immune Checkpoint Inhibitors by Reversing Tumor-Induced Immunosuppression" @default.
- W4362493312 doi "https://doi.org/10.1158/1535-7163.c.6538696.v1" @default.
- W4362493312 hasPublicationYear "2023" @default.
- W4362493312 type Work @default.
- W4362493312 citedByCount "0" @default.
- W4362493312 crossrefType "posted-content" @default.
- W4362493312 hasAuthorship W4362493312A5001816025 @default.
- W4362493312 hasAuthorship W4362493312A5006528431 @default.
- W4362493312 hasAuthorship W4362493312A5006809501 @default.
- W4362493312 hasAuthorship W4362493312A5026623309 @default.
- W4362493312 hasAuthorship W4362493312A5031638977 @default.
- W4362493312 hasAuthorship W4362493312A5032279076 @default.
- W4362493312 hasAuthorship W4362493312A5061558144 @default.
- W4362493312 hasAuthorship W4362493312A5066301151 @default.
- W4362493312 hasAuthorship W4362493312A5071544928 @default.
- W4362493312 hasAuthorship W4362493312A5082159021 @default.
- W4362493312 hasConcept C159654299 @default.
- W4362493312 hasConcept C167672396 @default.
- W4362493312 hasConcept C203014093 @default.
- W4362493312 hasConcept C2776090121 @default.
- W4362493312 hasConcept C2777701055 @default.
- W4362493312 hasConcept C2780674031 @default.
- W4362493312 hasConcept C2908647359 @default.
- W4362493312 hasConcept C42362537 @default.
- W4362493312 hasConcept C502942594 @default.
- W4362493312 hasConcept C542903549 @default.
- W4362493312 hasConcept C62478195 @default.
- W4362493312 hasConcept C71924100 @default.
- W4362493312 hasConcept C86803240 @default.
- W4362493312 hasConcept C8891405 @default.
- W4362493312 hasConcept C95444343 @default.
- W4362493312 hasConcept C99454951 @default.
- W4362493312 hasConceptScore W4362493312C159654299 @default.
- W4362493312 hasConceptScore W4362493312C167672396 @default.
- W4362493312 hasConceptScore W4362493312C203014093 @default.
- W4362493312 hasConceptScore W4362493312C2776090121 @default.
- W4362493312 hasConceptScore W4362493312C2777701055 @default.
- W4362493312 hasConceptScore W4362493312C2780674031 @default.
- W4362493312 hasConceptScore W4362493312C2908647359 @default.
- W4362493312 hasConceptScore W4362493312C42362537 @default.
- W4362493312 hasConceptScore W4362493312C502942594 @default.
- W4362493312 hasConceptScore W4362493312C542903549 @default.
- W4362493312 hasConceptScore W4362493312C62478195 @default.
- W4362493312 hasConceptScore W4362493312C71924100 @default.
- W4362493312 hasConceptScore W4362493312C86803240 @default.
- W4362493312 hasConceptScore W4362493312C8891405 @default.
- W4362493312 hasConceptScore W4362493312C95444343 @default.
- W4362493312 hasConceptScore W4362493312C99454951 @default.
- W4362493312 hasLocation W43624933121 @default.
- W4362493312 hasOpenAccess W4362493312 @default.
- W4362493312 hasPrimaryLocation W43624933121 @default.
- W4362493312 hasRelatedWork W2001861465 @default.
- W4362493312 hasRelatedWork W2131775812 @default.
- W4362493312 hasRelatedWork W2404290847 @default.
- W4362493312 hasRelatedWork W2789659603 @default.
- W4362493312 hasRelatedWork W2904909612 @default.
- W4362493312 hasRelatedWork W2984962695 @default.
- W4362493312 hasRelatedWork W3039388108 @default.
- W4362493312 hasRelatedWork W3120170523 @default.
- W4362493312 hasRelatedWork W3167775801 @default.
- W4362493312 hasRelatedWork W4225811843 @default.
- W4362493312 isParatext "false" @default.
- W4362493312 isRetracted "false" @default.
- W4362493312 workType "article" @default.